India, code on the label.
In India, Schedule H2 of the Drugs Rules, 1945 requires a barcode or QR code on the label of the listed drug brands, starting with the top 300 brands from 1 August 2023.
India's drug traceability starts on the label. Under Schedule H2 of the Drugs Rules, 1945, manufacturers of the listed brands, starting with the top 300, must print or affix a barcode or QR code carrying the product's details. The rule applies to every batch made on or after 1 August 2023, wherever the plant is. A notification of 22 June 2026 brings more medicines into Schedule H2, with antimicrobials covered from 1 July 2028.
India, in three facts.
India · Drugs Rules, 1945 · Schedule H2 inserted by G.S.R. 823(E), 17 November 2022 · barcode or QR code on the top 300 brands since 1 August 2023.
Under India's Drugs Rules, 1945, as amended by G.S.R. 823(E) of 17 November 2022, manufacturers of the brands listed in Schedule H2 must print or affix a barcode or QR code on the label from 1 August 2023.
Source: CDSCO, FAQs on G.S.R. 823(E)Any batch of a Schedule H2 brand manufactured on or after 1 August 2023 must carry the barcode or QR code, irrespective of where it was manufactured.
Source: CDSCO, FAQs on G.S.R. 823(E)A notification of 22 June 2026 brings further medicines into Schedule H2, making QR-code traceability mandatory for antimicrobials from 1 July 2028.
Source: Down To Earth, QR codes on antibiotics and India's fight against AMR
A code on the label, brand by brand.
A code on the listed brands
Manufacturers of the formulations listed in Schedule H2 print or affix a barcode or QR code on the label, on the primary pack or, where that is not possible, the secondary pack.
What the code carries
The product's identity: its names, the manufacturer, the batch, the manufacturing and expiry dates and the manufacturing licence number.
Wherever the plant is
Any batch of a listed brand manufactured on or after 1 August 2023 must carry the code, irrespective of where it was manufactured.
The list is growing
A June 2026 notification extends Schedule H2 to further medicines, with antimicrobials covered from 1 July 2028.
The timeline, as it stands.
The first phase, the top 300 brands, has applied since 1 August 2023. The government is now adding whole classes of medicine to Schedule H2.
Three moves that de-risk the deadline.
Check your brands against Schedule H2
Imports included: the rule follows the brand and the batch, not the plant.
Plan for the wider list
If you make antimicrobials or other medicines named in the 2026 notification, start artwork and line changes well before 2028.
Serve the EU and US from the same data
Indian plants that supply the EU and US also print the EU FMD and DSCSA identifiers. One data model can serve all three markets.
A label check a copy cannot pass.
A QR code tells a buyer what the pack claims to be, and a copied QR code tells them the same thing. Aeroz adds an identity to the pack or case that answers each tap with a signed response, so a distributor or pharmacist can tell the genuine product from a pack carrying a copied code.
India, answered.
What is Schedule H2?
A schedule added to India's Drugs Rules, 1945 by G.S.R. 823(E) of 17 November 2022. It lists the drug formulations that must carry a barcode or QR code on the label, starting with the top 300 brands.
From when is the QR code mandatory?
For the top 300 brands, on every batch manufactured on or after 1 August 2023.
Does it apply to imported medicines?
The CDSCO says any batch of a listed brand manufactured on or after 1 August 2023 must carry the code, irrespective of where it was manufactured.
Is India extending the rule?
Yes. A notification of 22 June 2026 brings more medicines into Schedule H2, with antimicrobials covered from 1 July 2028.
Know exactly where you stand, in 14 days.
A fixed-fee Aeroz audit maps your products against India's Schedule H2 barcode and QR requirements and export traceability and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.